1218: The-little-biotech-company-that-couldn't gets very lucky. @GZuckerman
Image: Brewing (https://en.wikipedia.org/wiki/Brewing) was an early application of biotechnology The-little-biotech-company-that-couldn't gets very lucky. @GZuckerman Gregory Zuckerman, @GZuckerman, Wall Street Journal Special Writer, in re: The virus: little company, Novavax, that couldn’t. Virus solution now worth billions. In March 2020, the CEO was blunt: we need money to dvp what we see as a breakthrough that won’t need [extreme] refrigeration.” They got funds from the US govt, the Gates Foundation, and hedge funds— $2 billion—and it seems to have come through. On the prcpice of getting FDA authorization. Stock was $4, now over $200. Amazingly, the giants Merck, GSK, and others, have not succeeded. https://www.wsj.com/articles/novavax-nears-covid-19-vaccine-game-changerafter-years-of-failure-11614096579?mod=hp_lead_pos4